All patients n=1233 Dupilumab n=631 Other systemics n=107 Limited/no treatment n=495
Severity
0 (n, %) 947 (77%) 492 (78%) 73 (68%) 382 (77%)
1 (n, %) 204 (16%) 110 (17%) 18 (17%) 76 (15%)
2 (n,%) 78 (6%) 29 (5%) 15 (14%) 34 (7%)
3 (n,%) 4 (0.3%) 0 (0%) 1 (1%) 3 (1%)
4/5 (n, %) 0 (0%) 0 (0%) 0 (0%) 0 (0%)